Yüklüyor......
Liraglutide and obesity: a review of the data so far
The prevalence of obesity worldwide has nearly doubled since 1980 with current estimates of 2.1 billion in 2013. Overweight and obesity lead to numerous adverse conditions including type 2 diabetes, cardiovascular disease, stroke, and certain cancers. The worldwide spread of obesity and associated c...
Kaydedildi:
| Yayımlandı: | Drug Des Devel Ther |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386791/ https://ncbi.nlm.nih.gov/pubmed/25848222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S58459 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|